| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2023 ( Subtotal = $489,533 ) |
| 2023 | 2023 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 000 | 5 | 2/3/2023 | NON-COMPETING CONTINUATION | $489,533 |
|
| Issue Date FY: 2022 ( Subtotal = $489,534 ) |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 004 | 4 | 8/2/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $224,092 |
| 2022 | 2022 | FRED HUTCHINSON CANCER CENTER | 1100 FAIRVIEW AVE N | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 002 | 4 | 6/8/2022 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $489,534 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 003 | 3 | 8/2/2022 | NON-COMPETING CONTINUATION | -$224,092 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 001 | 3 | 6/8/2022 | NON-COMPETING CONTINUATION | $0 |
| 2022 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 000 | 3 | 2/3/2022 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,032,791 ) |
| 2021 | 2021 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 000 | 3 | 1/14/2021 | NON-COMPETING CONTINUATION | $1,032,791 |
|
| Issue Date FY: 2020 ( Subtotal = $286,955 ) |
| 2020 | 2020 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 000 | 2 | 1/31/2020 | NON-COMPETING CONTINUATION | $286,955 |
|
| Issue Date FY: 2019 ( Subtotal = $583,532 ) |
| 2019 | 2019 | FRED HUTCHINSON CANCER RESEARCH CENTER | 1100 FAIRVIEW AVE N J6-300 | SEATTLE | WA | 98109 | KING | USA | Cancer Treatment Research | 000 | 1 | 2/1/2019 | NEW | $583,532 |
|
|